Valuation North China Pharmaceutical Company.Ltd

Stocks

End-of-day quote Shanghai S.E. 2026-09-11			5-day change	1st Jan Change
4.940 ^CNY	-4.63%		+5.33%	-10.67%

08-21	North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-04	North China Pharmaceutical's Eight Products Win Preliminary Bids Under Government Drug Procurement Program	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	16,781	20,452	10,981	9,780	8,870	9,488
Change	-	21.87%	-46.31%	-10.94%	-9.3%	6.96%
Enterprise Value (EV) ¹	25,126	28,923	20,346	19,939	18,660	19,162
Change	-	15.11%	-29.65%	-2%	-6.41%	2.69%
P/E	172x	1,084x	-15.9x	1,900x	69.9x	51.7x
PBR	2.74x	3.36x	2.07x	1.84x	1.65x	1.72x
PEG	-	-13.3x	0x	-19x	0x	1.2x
Capitalization / Revenue	1.46x	1.97x	1.05x	0.97x	0.9x	1.03x
EV / Revenue	2.19x	2.79x	1.94x	1.97x	1.89x	2.07x
EV / EBITDA	20.8x	23.7x	15.2x	15.7x	12.9x	12.6x
EV / EBIT	42x	48.2x	32.1x	37.2x	28.3x	30.6x
EV / FCF	-30.9x	-32x	112x	128x	49.1x	35.2x
FCF Yield	-3.24%	-3.12%	0.89%	0.78%	2.03%	2.84%
Dividend per Share ²	0.03	0.06	-	0.01	0.03	0.035
Rate of return	0.29%	0.5%	-	0.18%	0.58%	0.63%
EPS ²	0.06	0.011	-0.402	0.003	0.074	0.107
Distribution rate	50%	545%	-	333%	40.5%	32.7%
Net sales ¹	11,493	10,385	10,500	10,120	9,870	9,242
EBITDA ¹	1,209	1,221	1,343	1,272	1,447	1,517
EBIT ¹	597.9	600.1	634.8	536.4	658.9	627.2
Net income ¹	97.32	18.73	-689.2	4.89	127	183.1
Net Debt ¹	8,345	8,472	9,366	10,159	9,790	9,674
Reference price ²	10.290	11.920	6.400	5.700	5.170	5.530
Nbr of stocks (in thousands)	1,630,805	1,715,730	1,715,730	1,715,730	1,715,730	1,715,730
Announcement Date	4/28/21	4/27/22	4/21/23	3/29/24	3/27/25	4/17/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NORTH CHINA PHARMACEUTICAL COMPANY.LTD	-	-	-	-	1.26B
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	994B
JOHNSON & JOHNSON	29.54x	-	-	2.02%	640B
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	454B
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	337B
NOVARTIS AG	19.41x	5.08x	12.59x	3.21%	261B
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	246B
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	204B
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	190B
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	178B
Average	16.16x	6.27x	15.06x	2.51%	350.6B
Weighted average by Cap.	23.19x	7.72x	17.10x	2.05%